Combination of methyl ((1S) - 1 - ((2S) - 2 - (5 - (4 '- (2 - ((2S) - 2 - (Methoxycarbonyl) amino) - 3 - metilbutanoil) - 2 - pirrolidinil) - 1H imidazole - 5 - il) - 4 - bifenilil) - 1H imidazole - il - 2 - 1 - pirrolidinil) carbonyl) - 2-methylpropyl) carbamate (daclatasvir) and N - (tert Butoxycarbonyl) - 3 - methyl - l-valyl - (4R) - 7 - (4 - (4 - methoxy - chlorine - 1 - ISO Quinolinil Oxy) - N - ((1R,(2S) - 1 - (cyclopropylsulfonyl) Carbamoyl) - 2 - vinilciclopropil) - L - (prolinamida asunaprevir).

摘要

Referring to a composition comprising a compound of formula (i), which is Methyl ((1S) - 1 - ((2S) - 2 - (5 - (4 '- (2 - ((2S) - 2 - (Methoxycarbonyl) amino) - 3 - metilbutanoil) - 2 - pirrolidinil) - 1H imidazole - 5 - il) - 4 - bifenilil) - 1H imidazole - il - 2 - 1 - pirrolidinil) carbonyl) - 2-methylpropyl) carbamate (daclatasvir) and co Mpuesto of formula (ii),Which is (tert Butoxycarbonyl) - 3 - methyl - l-valyl - (4R) - 4 - (7 - (4 - methoxy - chlorine - 1 - isoquinolinil Oxy) - N - ((1R, 2S) - 1 - ((cyclopropylsulfonyl) Carbamoyl) - 2 - vinilciclopropil) - L - prolinamida (asunaprevir). The composition can inhibit the hepatitis C virus (HCV), being useful in the treatment of Type C Hepatitis